Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasia Pulkina

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmaceutics|June 26, 2026
A CXCL10-Expressing Influenza Vector Induces Robust Adaptive Immunity Despite Strong AttenuationOlga Ozhereleva, Alina Mustafaeva, Anastasia Pulkina, et al.
International Journal of Molecular Sciences|July 29, 2023
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in MiceAnastasia Pulkina, Kirill Vasilyev, Arman Muzhikyan, et al.
Vaccines|January 24, 2025
Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone MiceMariia V Sergeeva, Kirill Vasilev, Ekaterina Romanovskaya-Romanko, et al.
Vaccines|November 27, 2021
Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX AntigensKirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, et al.
Vaccines|April 30, 2021
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against <i>Mycobacterium tuberculosis</i> in Mice and Guinea PigsMariia Sergeeva, Ekaterina Romanovskaya-Romanko, Natalia Zabolotnyh, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmaceutics|June 26, 2026
A CXCL10-Expressing Influenza Vector Induces Robust Adaptive Immunity Despite Strong AttenuationOlga Ozhereleva, Alina Mustafaeva, Anastasia Pulkina, et al.
International Journal of Molecular Sciences|July 29, 2023
IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in MiceAnastasia Pulkina, Kirill Vasilyev, Arman Muzhikyan, et al.
Vaccines|January 24, 2025
Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone MiceMariia V Sergeeva, Kirill Vasilev, Ekaterina Romanovskaya-Romanko, et al.
Vaccines|November 27, 2021
Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX AntigensKirill Vasilyev, Anna-Polina Shurygina, Natalia Zabolotnykh, et al.
Vaccines|April 30, 2021
Mucosal Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens Provides Protection against <i>Mycobacterium tuberculosis</i> in Mice and Guinea PigsMariia Sergeeva, Ekaterina Romanovskaya-Romanko, Natalia Zabolotnyh, et al.
Pageof 1